REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 140 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,367,678 | -6.9% | 627,445 | -10.1% | 0.00% | -25.0% |
| Q2 2023 | $18,662,914 | -24.2% | 697,679 | -38.6% | 0.00% | -20.0% |
| Q1 2023 | $24,607,016 | +3.2% | 1,136,058 | +13.5% | 0.01% | 0.0% |
| Q4 2022 | $23,848,989 | +16.2% | 1,001,217 | -3.8% | 0.01% | 0.0% |
| Q3 2022 | $20,517,000 | +18.3% | 1,040,426 | +17.0% | 0.01% | +25.0% |
| Q2 2022 | $17,336,000 | -21.8% | 889,497 | +2.3% | 0.00% | -20.0% |
| Q1 2022 | $22,181,000 | +26.9% | 869,507 | +25.3% | 0.01% | +66.7% |
| Q4 2021 | $17,473,000 | -34.8% | 694,203 | -28.7% | 0.00% | -50.0% |
| Q3 2021 | $26,792,000 | +19.9% | 973,898 | +38.3% | 0.01% | +20.0% |
| Q2 2021 | $22,353,000 | -31.1% | 704,257 | -0.3% | 0.01% | -37.5% |
| Q1 2021 | $32,423,000 | +61.5% | 706,691 | +39.4% | 0.01% | +60.0% |
| Q4 2020 | $20,074,000 | +972.3% | 507,066 | +842.6% | 0.01% | +400.0% |
| Q3 2020 | $1,872,000 | -54.0% | 53,794 | -58.3% | 0.00% | 0.0% |
| Q2 2020 | $4,068,000 | +182.7% | 128,850 | +96.2% | 0.00% | 0.0% |
| Q1 2020 | $1,439,000 | – | 65,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $175,333,000 | 30.61% |
| TRV GP IV, LLC | 1,419,900 | $45,068,000 | 21.46% |
| Ponoi II Management, LLC | 685,011 | $21,742,000 | 17.62% |
| Column Group LLC | 3,347,245 | $106,242,000 | 15.04% |
| Ponoi Management, LLC | 685,011 | $21,742,000 | 12.08% |
| Boxer Capital, LLC | 3,484,264 | $110,591,000 | 3.90% |
| Cormorant Asset Management, LP | 3,338,166 | $105,953,000 | 3.60% |
| BVF INC/IL | 2,485,049 | $78,875,000 | 2.96% |
| Casdin Capital, LLC | 2,305,000 | $73,161,000 | 1.86% |
| Burrage Capital Management LLC | 50,000 | $1,587,000 | 1.59% |